Cargando…

Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate

The Thomsen-Friedenreich (TF) antigen is a key target for the development of anticancer vaccines, and this ongoing challenge remains relevant due to the poor immunogenicity of the TF antigen. To overcome this challenge, we adopted a bivalent conjugate design which introduced both the TF antigen and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kleski, Kristopher A., Trabbic, Kevin R., Shi, Mengchao, Bourgault, Jean-Paul, Andreana, Peter R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144725/ https://www.ncbi.nlm.nih.gov/pubmed/32183149 http://dx.doi.org/10.3390/molecules25061319

Ejemplares similares

Chemical synthesis and immunological evaluation of entirely carbohydrate conjugate Globo H-PS A1
por: Ghosh, Samir, et al.
Publicado: (2020)

The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule.
por: Dippold, W, et al.
Publicado: (1990)

Interaction of the Oncofetal Thomsen–Friedenreich Antigen with Galectins in Cancer Progression and Metastasis
por: Sindrewicz, Paulina, et al.
Publicado: (2016)

The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer
por: Kurtenkov, Oleg, et al.
Publicado: (2018)

Expression of Thomsen–Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability
por: Leão, Beatriz, et al.
Publicado: (2021)

Structural Basis for Distinct Binding Properties of the Human Galectins to Thomsen-Friedenreich Antigen
por: Bian, Cheng-Feng, et al.
Publicado: (2011)

Glycoamino Acid Analogues of the Thomsen–Friedenreich Tumor-Associated Carbohydrate Antigen: Synthesis and Evaluation of Novel Antiproliferative Factor Glycopeptides
por: Siddiqui, Maqbool A., et al.
Publicado: (2017)

Isolipoic acid-linked gold nanoparticles bearing the thomsen friedenreich tumor-associated carbohydrate antigen: Stability and in vitro studies
por: Mondal, Utpal K., et al.
Publicado: (2022)

Contribution of Thomsen-Friedenreich antigens to bladder cancer malignancy: Characterization of cell line models
por: Severino, Paulo F, et al.
Publicado: (2010)

A One-Step Chemoenzymatic Labeling Strategy for Probing Sialylated Thomsen–Friedenreich Antigen
por: Wen, Liuqing, et al.
Publicado: (2018)

Synthesis of the Thomsen-Friedenreich-antigen (TF-antigen) and binding of Galectin-3 to TF-antigen presenting neo-glycoproteins
por: Hoffmann, Marius, et al.
Publicado: (2020)

The Thomsen-Friedenreich Antigen: A Highly Sensitive and Specific Predictor of Microsatellite Instability in Gastric Cancer
por: Mereiter, Stefan, et al.
Publicado: (2018)

Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
por: Kurtenkov, Oleg
Publicado: (2020)

Stable Gold-Nanoparticle-Based Vaccine for the Targeted Delivery of Tumor-Associated Glycopeptide Antigens
por: Trabbic, Kevin R., et al.
Publicado: (2021)

Exposure of Thomsen-Friedenreich Antigen on the Renal Tubules of a Patient with Capnocytophaga Infection-induced Acute Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2021)

Evaluation of a novel fluorescent nanobeacon for targeted imaging of Thomsen-Friedenreich associated colorectal cancer
por: Nakase, Hiroshi, et al.
Publicado: (2017)

Determination of thermodynamic parameters of Xerocomus chrysenteron lectin interactions with N-acetylgalactosamine and Thomsen-Friedenreich antigen by isothermal titration calorimetry
por: Damian, Luminita, et al.
Publicado: (2005)

Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer
por: Kurtenkov, Oleg, et al.
Publicado: (2015)

CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
por: Dragon, Anna Christina, et al.
Publicado: (2023)

Increased Sialylation of Anti-Thomsen-Friedenreich Antigen (CD176) Antibodies in Patients with Gastric Cancer: A Diagnostic and Prognostic Potential
por: Kurtenkov, Oleg, et al.
Publicado: (2014)

The Potential Action of Thomsen–Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer
por: Peng, Ying, et al.
Publicado: (2020)

Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance
por: Kurtenkov, Oleg, et al.
Publicado: (2017)

Identification and Targeting of Thomsen–Friedenreich and IL1RAP Antigens on Chronic Myeloid Leukemia Stem Cells Using Bi-Specific Antibodies
por: Eldesouki, Raghda E, et al.
Publicado: (2021)

Preclinical Analysis of JAA-F11, a Specific Anti–Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging
por: Karacosta, Loukia G., et al.
Publicado: (2018)

Synthesis and biological evaluation of a novel MUC1 glycopeptide conjugate vaccine candidate comprising a 4’-deoxy-4’-fluoro-Thomsen–Friedenreich epitope
por: Johannes, Manuel, et al.
Publicado: (2015)

Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis
por: Tati, Swetha, et al.
Publicado: (2017)

Cell surface Thomsen-Friedenreich proteome profiling of metastatic prostate cancer cells reveals potential link with cancer stem cell-like phenotype
por: Li, Feng, et al.
Publicado: (2017)

Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses
por: Nishat, Sharmeen, et al.
Publicado: (2016)

Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau
por: Starbuck, Kristen, et al.
Publicado: (2018)

Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733]
por: Tati, Swetha, et al.
Publicado: (2017)

Thomsen and myotonia congenita.
por: Johnson, J
Publicado: (1968)

Myotonia Congenita. Thomsen's Disease
por: Variava, N. S.
Publicado: (1949)

Myotonia Congenita (Thomsen's Disease)
por: Chand, Amir, et al.
Publicado: (1945)

Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models
por: Ghazal, Diala, et al.
Publicado: (2022)

A New Neurosis. (Thomsen's Disease)
por: Spencer, William H.
Publicado: (1884)

Thomsen’s Disease—A Family History
por: Clemesha, J. C.
Publicado: (1897)

Correction to Boeg Thomsen et al. (2021)
Publicado: (2022)

A Case of Myotonia Congenita (Thomsen's Disease) in a Child
por: Thomson, John
Publicado: (1916)

Bivalent EGFR-Targeting DARPin-MMAE Conjugates
por: Karsten, Lennard, et al.
Publicado: (2022)

Entirely enzymatic nanofabrication of DNA–protein conjugates
por: Bernardinelli, Giulio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1fgdkfl7vs2eqrh76hk9pfarfv